Beverly S. Mitchell

8.0k citations
126 papers · 6.0k · 1 hit paper · h-index 46

Impact in

  • Physiology top 0.1%
    • Adenosine and Purinergic Signaling
  • Hematology top 1%
    • Acute Myeloid Leukemia Research

Papers in

    • Biochemical and Molecular Research 62
    • RNA modifications and cancer 12
    • Cytomegalovirus and herpesvirus research 36

Beverly S. Mitchell

118 papers receiving 5.7k citations

Beverly S. Mitchell's Hit Papers

Phase I Trial of the Proteasome Inhibitor PS-341 in Patients With Refractory Hematologic Malignancies 2002 · 608 citations
6080+8+16Years since publication200400600

Peers

Beverly S. Mitchell
Comparison fields: 5 of 122
  • Physiology 944
  • Hematology 961
  • Transplantation 218
  • Genetics 637
  • Molecular Biology 3.5k
Replace Johannes Drach with:
Johannes Drach Austria
Nathalie Bonnefoy France
Naoko Takebe United States
James F. Beck Germany
Alessandro Pileri Italy
Therese Wiedmer United States
Charles J. Parker United States
Fabien Calvo France
Yoichi Imai Japan
Didier Bouscary France
Beverly S. Mitchell relative to Johannes Drach Austria Johannes Drach's profile →
Citations per field
00.5×6.9×
Johannes Drach · 1×
Citations per year

Countries citing papers authored by Beverly S. Mitchell

Since Specialization
Citations

This map shows the geographic impact of Beverly S. Mitchell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beverly S. Mitchell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beverly S. Mitchell more than expected).

Fields of papers citing papers by Beverly S. Mitchell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beverly S. Mitchell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beverly S. Mitchell. The network helps show where Beverly S. Mitchell may publish in the future.

Co-authors

The 25 scholars most cited alongside Beverly S. Mitchell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Beverly S. Mitchell Line = papers co-authored together Beverly S. Mitchell links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 126 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Phase I Trial of the Proteasome Inhibitor PS-341 in Patients With Refractory Hematologic Malignancies
Hit paper breakdown →
2002608
2 2002251
3 2005228
4 2007221
5 1991143
6 2005140
7 1981127
8 1991121
9 1992120
10 1995108
11
Resistance to 1-beta-D-arabinofuranosylcytosine in human T-lymphoblasts mediated by mutations within the deoxycytidine kinase gene.
1992105
12 1996102
13 2004102
14 2005100
15 198097
16 200397
17 200195
18 199895
19 199291
20
Retroviral transfer of deoxycytidine kinase into tumor cell lines enhances nucleoside toxicity.
199689

About Beverly S. Mitchell

Beverly S. Mitchell is a scholar working on Molecular Biology, Epidemiology, Physiology, Hematology and Public Health, Environmental and Occupational Health, having authored 126 papers that have together received 6.0k indexed citations. Recurring topics across this work include Biochemical and Molecular Research (62 papers), Adenosine and Purinergic Signaling (36 papers), Cytomegalovirus and herpesvirus research (36 papers), HIV/AIDS drug development and treatment (15 papers), Acute Lymphoblastic Leukemia research (14 papers), Acute Myeloid Leukemia Research (14 papers), RNA modifications and cancer (12 papers) and Chronic Lymphocytic Leukemia Research (8 papers). The work is most often cited by research in Physiology (944 citations), Hematology (961 citations), Transplantation (218 citations), Genetics (637 citations) and Molecular Biology (3.5k citations). Beverly S. Mitchell has collaborated with scholars based in United States, Germany and India. Frequent co-authors include Józef Spychała, Kiran Mahajan, Sally A. Hunsucker, Donna S. Shewach, Craig B. Thompson, Jennifer S. Dayton, Jing Gu, Albert Zimmermann, Laurence A. Turka and Dale A. Ramsden. Their work appears in journals such as Blood, Journal of Biological Chemistry, Advances in experimental medicine and biology, Journal of Clinical Investigation and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact